1-9 of 9
Olivier Lavergne
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Blocking heterotrimeric G-protein complex by a small-molecule inhibitor as a potential therapy for human tumors.

Gregoire Prevost, Marjorie Damian, Samir Attoub, Mohammed Ayoub, Jean-Philippe Pin, Jean-Louis Baneres, Muriel Petit, Gaelle Depierre, Francesca De Giorgi, Marie-Christine Brezak, Helene Coulomb, Sophie Chaumeron, Eric Ferrandis, Pierre Roubert, Daniele Demarquay, Olivier Lavergne, Christophe Thurieau, Francois Ichas, Sandrine Silvente-Poirot, Gilles Favre, Marc Poirot, Mark Carlson, Olivier De Wever, Franck Gieseler, Christian Gespach, Philip Kasprzyk
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 3439.
Published: 01 May 2008
View article titled, Blocking heterotrimeric G-protein complex by a small-molecule inhibitor as a potential therapy for human tumors.
Journal Articles

Characterization of the physical interaction between the CDC25 phosphatase inhibitor IRC-083864 and its target and its biological effects on human cancer cell lines

Marie-Christine Brezak, Muriel Quaranta, Marion Huchet, Celine Frongia, Annie Valette, Marie-Odile Galcera, Olivier Lavergne, Dennis Bigg, Philip Kasprzyk, Eric Ferrandis, Gregoire Prevost, Bernard Ducommon
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 754.
Published: 01 May 2008
View article titled, Characterization of the physical interaction between the CDC25 phosphatase inhibitor IRC-083864 and its target and its biological effects on human cancer cell lines
Journal Articles

A novel synthetic CDC25 phosphatase inhibitor inhibits human cancer growth in vitro and in vivo

Gregoire Prevost, Muriel Quaranta, Marie-Cristine Brezak, Celine Frongia, Alban Sidhu, Sophie Chaumeron, Marie-Odile Galcera, Olivier Lavergne, Dennis Bigg, Annie Valette, Philip Kasprzyk, Bernard Ducommun
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 3228.
Published: 01 May 2007
View article titled, A novel synthetic CDC25 phosphatase inhibitor inhibits human cancer growth <em>in vitro</em> and <em>in vivo</em>
Journal Articles

Inhibition of human tumor cell growth in vivo by an orally bioavailable inhibitor of CDC25 phosphatases: BN83065

Marie Christine Brezak, Muriel Quaranta, Odile Mondésert, Marie-Odile Galcera, Olivier Lavergne, Philip Kasprzyk, Bernard Ducommun, Gregoire P. Prevost
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 154.
Published: 01 May 2005
View article titled, Inhibition of human tumor cell growth <em>in vivo</em> by an orally bioavailable inhibitor of CDC25 phosphatases: BN83065
Journal Articles

BN80927: A Novel Homocamptothecin That Inhibits Proliferation of Human Tumor Cells in Vitro and in Vivo

Danièle Demarquay, Marion Huchet, Helène Coulomb, Laurence Lesueur-Ginot, Olivier Lavergne, José Camara, Philip G. Kasprzyk, Grégoire Prévost, Dennis C. H. Bigg
Journal: Cancer Research
Cancer Res (2004) 64 (14): 4942–4949.
https://doi.org/10.1158/0008-5472.CAN-03-3872
Published: 15 July 2004
View article titled, BN80927: <subtitle>A Novel Homocamptothecin That Inhibits Proliferation of Human Tumor Cells <em>in Vitro</em> and <em>in Vivo</em> </subtitle>
Open the PDF for BN80927: <subtitle>A Novel Homocamptothecin That Inhibits Proliferation of Human Tumor Cells <em>in Vitro</em> and <em>in Vivo</em> </subtitle> in another window
Journal Articles

A Novel Synthetic Inhibitor of CDC25 Phosphatases: BN82002

Marie-Christine Brezak, Muriel Quaranta, Odile Mondésert, Marie-Odile Galcera, Olivier Lavergne, Frédéric Alby, Martine Cazales, Véronique Baldin, Christophe Thurieau, Jeremiath Harnett, Christophe Lanco, Philip G. Kasprzyk, Gregoire P. Prevost, Bernard Ducommun
Journal: Cancer Research
Cancer Res (2004) 64 (9): 3320–3325.
https://doi.org/10.1158/0008-5472.CAN-03-3984
Published: 03 May 2004
View article titled, A Novel Synthetic Inhibitor of CDC25 Phosphatases: <subtitle>BN82002</subtitle>
Open the PDF for A Novel Synthetic Inhibitor of CDC25 Phosphatases: <subtitle>BN82002</subtitle> in another window
Journal Articles

A novel synthetic inhibitor of CDC25 phosphatase : BN82002

Marie Christine Brezak, M. Quaranta, Odile Mondesert, Marie Odile Galcera, J. Harnett, C. Thurieau, Olivier Lavergne, C. Lanco, P. Kasprzyk, B. Ducommun, Gregoire P. Prevost
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 895.
Published: 01 April 2004
View article titled, A novel synthetic inhibitor of CDC25 phosphatase : BN82002
Journal Articles

Unusual Potency of BN 80915, a Novel Fluorinated E-ring Modified Camptothecin, toward Human Colon Carcinoma Cells

Annette K. Larsen, Cristèele Gilbert, Ginette Chyzak, Sergey Y. Plisov, Irina Naguibneva, Olivier Lavergne, Laurence Lesueur-Ginot, Dennis C. H. Bigg
Journal: Cancer Research
Cancer Res (2001) 61 (7): 2961–2967.
Published: 01 April 2001
View article titled, Unusual Potency of BN 80915, a Novel Fluorinated E-ring Modified Camptothecin, toward Human Colon Carcinoma Cells
Open the PDF for Unusual Potency of BN 80915, a Novel Fluorinated E-ring Modified Camptothecin, toward Human Colon Carcinoma Cells in another window
Journal Articles

Homocamptothecin, an E-Ring Modified Camptothecin with Enhanced Lactone Stability, Retains Topoisomerase I-targeted Activity andAntitumor Properties

Laurence Lesueur-Ginot, Danièle Demarquay, Robert Kiss, Philip G. Kasprzyk, Laurent Dassonneville, Christian Bailly, José Camara, Olivier Lavergne, Dennis C. H. Bigg
Journal: Cancer Research
Cancer Res (1999) 59 (12): 2939–2943.
Published: 15 June 1999
View article titled, Homocamptothecin, an E-Ring Modified Camptothecin with Enhanced Lactone Stability, Retains Topoisomerase I-targeted Activity andAntitumor Properties
Open the PDF for Homocamptothecin, an E-Ring Modified Camptothecin with Enhanced Lactone Stability, Retains Topoisomerase I-targeted Activity andAntitumor Properties in another window